These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31495986)

  • 21. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 correlates with microRNA-125b/microRNA-146a/microRNA-203 and predicts 2-year restenosis risk in coronary heart disease patients.
    Zhu Y; Zhu Y; Liu Y; Liu Y; Chen X
    Biomark Med; 2021 Mar; 15(4):257-271. PubMed ID: 33565328
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic Performance of Circulating miRNAs and Extracellular Vesicles in Acute Ischemic Stroke.
    Eyileten C; Jakubik D; Shahzadi A; Gasecka A; van der Pol E; De Rosa S; Siwik D; Gajewska M; Mirowska-Guzel D; Kurkowska-Jastrzebska I; Czlonkowska A; Postula M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.
    Gabbasov Z; Kozlov S; Byazrova S; Saburova O; Melnikov I; Caprnda M; Curilla E; Gaspar L; Kruzliak P; Smirnov V
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):898-905. PubMed ID: 27637207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies.
    Gil RJ; Bil J; Kern A; Iñigo-Garcia LA; Formuszewicz R; Dobrzycki S; Vassilev D; Mehran R
    Cardiovasc Ther; 2020; 2020():6760205. PubMed ID: 32411301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
    Garcia S; Murray ST; Moritz TE; Pierpont G; Goldman S; Larsen GC; Littooy F; Ward HB; McFalls EO
    Ann Vasc Surg; 2010 Jul; 24(5):596-601. PubMed ID: 20579583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
    Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
    Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
    Cassese S; Byrne RA; Tada T; Pinieck S; Joner M; Ibrahim T; King LA; Fusaro M; Laugwitz KL; Kastrati A
    Heart; 2014 Jan; 100(2):153-9. PubMed ID: 24270744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
    Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
    Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
    Tanaka K; Li H; Curran PJ; Takano Y; Arbit B; Currier JW; Yeatman LA; Kobashigawa JA; Tobis JM
    Am J Cardiol; 2006 Apr; 97(8):1192-7. PubMed ID: 16616025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
    Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
    Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
    Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation.
    Zhao J; Wang X; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2020 Aug; 189(3):907-915. PubMed ID: 31989420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
    Mito T; Miura S; Iwata A; Morii J; Sugihara M; Ike A; Mori K; Kawamura A; Nishikawa H; Zhang B; Saku K
    Coron Artery Dis; 2011 Nov; 22(7):451-7. PubMed ID: 21811155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
    Chen W; Li S
    Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction.
    Liu X; Yuan L; Chen F; Zhang L; Chen X; Yang C; Han Z
    Clin Lab; 2017 Jan; 63(1):101-109. PubMed ID: 28164501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.